[Course and prognosis of infantile epilepsy in relation to present-day treatment].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001927:Brain Diseases / Q000150:complications; D002220:Carbamazepine / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D004832:Epilepsy, Absence / Q000209:etiology; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000209:etiology; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use; D007223:Infant; D012075:Remission, Spontaneous; D013997:Time Factors
D000927:Anticonvulsants; D006827:Hydantoins; D002220:Carbamazepine; D000324:Adrenocorticotropic Hormone
Evoluzione e prognosi dell'epilessia infantile in rapporto alle attuali terapie.